Surgery
Audio Summaries

Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome

This study investigates the efficacy and safety of etuvetidigene autotemcel (etu-cel), an autologous gene therapy, for treating Wiskott-Aldrich syndrome, a rare genetic disorder. The results indicate a high overall survival rate of 96% at both 1 and 5 years post-treatment, along with a significant reduction in severe infections and bleeding events after therapy. The findings suggest that etu-cel provides a sustained clinical benefit for patients with this condition.

Real-World Analysis of Neoadjuvant Immunochemotherapy Followed by Surgery in Esophageal Cancer with Baseline Supraclavicular Lymph Node Involvement

This study investigates the prognosis of esophageal squamous cell carcinoma (ESCC) patients with baseline supraclavicular lymph node (SCLN) involvement who received neoadjuvant immunochemotherapy (nICT) followed by surgery. The authors found that patients with clinically positive SCLN had comparable recurrence-free survival and overall survival to those with clinically negative nodes, although those with persistent pathological SCLN positivity had worse outcomes. The study suggests that postoperative radiotherapy may be beneficial for patients with residual SCLN positivity.

Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer

The authors aimed to evaluate the long-term efficacy of adjuvant S-1 in improving overall survival (OS) in patients with resected biliary tract cancer (BTC) compared to observation alone. The 5-year follow-up results from the ASCOT trial demonstrated that S-1 significantly improved OS (64% vs. 52%) and median OS (8.2 years vs. 5.9 years), confirming its sustained survival benefit and supporting its use as a standard treatment for resected BTC.

Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial

The study aimed to determine whether intravenous tenecteplase administered before endovascular thrombectomy (EVT) improves outcomes in patients with moderate to severe basilar artery occlusion presenting 4.5 to 24 hours after stroke onset. The findings revealed no significant difference in functional independence or safety outcomes between the tenecteplase plus EVT group and the EVT alone group, suggesting that the addition of tenecteplase does not enhance recovery in this patient population.

Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis

The authors aimed to determine whether screening with a multicancer early-detection test, in addition to usual care, reduces the incidence of late-stage cancers (stage III or IV) compared to usual care alone. In a randomized controlled trial involving over 142,000 participants, they found no significant difference in the incidence rates of stage III or IV cancers between the two groups after three screening rounds. While there was a trend towards a lower incidence of stage IV cancers, the results were not conclusive, indicating the need for further follow-up.

Clinical Uses of Common Genetic Variants Associated with Common Diseases

The authors investigate why the integration of polygenic risk scores and genomic knowledge into clinical practice for common adult-onset diseases has been slow, despite advancements in genomics and the identification of numerous genetic variants associated with these conditions. They explore potential applications of these scores and pharmacogenomics in improving prevention and treatment strategies as genome sequencing becomes more accessible.

Increased Medical Debt in Collections 1 Year After Emergency General Surgery Admission

The authors aimed to determine whether emergency general surgery (EGS) admissions are linked to lasting increases in medical debt and how this is influenced by patient demographics versus treatment factors. They found that nearly 10% of patients experienced increased medical debt in collections within a year after EGS, with significant associations identified between income levels and insurance status, rather than the intensity of medical treatment. This suggests that financial risk protection strategies may be more effective in addressing post-EGS financial burdens than altering clinical care practices.

Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma

This phase 1 study investigates the safety and efficacy of anitocabtagene autoleucel (anito-cel), a BCMA-directed CAR T-cell therapy, in patients with relapsed or refractory multiple myeloma who have undergone multiple prior treatments. The results indicate a high response rate (100%) with a significant proportion achieving complete response (79%), while adverse events, particularly cytokine release syndrome and neurotoxicity, were mostly mild. The findings suggest that anito-cel may be a promising treatment option for this challenging patient population.

Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead

This paper aims to address the adverse impacts of peripheral arterial disease (PAD) and the disparities in outcomes among affected populations. The authors highlight the significant individual and societal burdens of PAD, particularly on underserved groups, and propose both short-term and long-term strategies to improve management and access to care, including enhanced awareness and multidisciplinary treatment approaches. The study emphasizes the need for targeted interventions to reduce the prevalence and consequences of PAD, especially in vulnerable communities.

Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment

The authors review current advancements in the management of peripheral arterial disease (PAD), particularly focusing on the effectiveness of medical therapy, supervised exercise, and the judicious use of revascularization procedures. They aim to address how to optimize treatment strategies to reduce cardiovascular risks, improve quality of life, and minimize limb loss in patients with varying severity of PAD. The paper highlights the complexities of PAD management due to its multifaceted nature and the potential overuse of invasive interventions.